“A Prospective Clinical Study for Safety and Efficacy of Intralesional Tuberculin Purified Protein Derivative in Treatment of Palmoplantar Verruca”. 2022. Journal of Nobel Medical College 11 (1): 12-16. https://doi.org/10.3126/jonmc.v11i1.45720.